Related Experiment Video

Updated: May 13, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Candidate agents for papillary thyroid cancer identified by gene expression analysis

Wei Zhu1, Chen Li, Zhilong Ai

  • 1Department of General Surgery, Zhongshan Hospital Affiliated to Fudan University, No.180 Fenglin Road, Xuhui District, Shanghai 200032, China.

Pathology Oncology Research : POR
|March 23, 2013
PubMed

Insights

This study identifies molecular targets and small molecules to reverse papillary thyroid cancer (PTC) by analyzing gene expression data. These findings offer new therapeutic strategies for PTC treatment.

Area of Science:

  • Oncology
  • Bioinformatics
  • Molecular Biology

Background:

  • Effective management of papillary thyroid cancer (PTC) requires a deeper understanding of its molecular mechanisms.
  • Current therapeutic strategies for PTC necessitate the identification of novel molecular targets and treatment approaches.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying papillary thyroid cancer (PTC).
  • To identify biologically active small molecules capable of reversing PTC-associated gene expression patterns.
  • To discover potential therapeutic agents for PTC.

Main Methods:

  • Downloaded and analyzed gene expression data for papillary thyroid cancer (PTC) from the Gene Expression Omnibus (GEO) database.
  • Employed computational bioinformatics to compare gene expression profiles between PTC and normal tissues.
  • Identified differentially expressed genes (DEGs) and enriched pathways.
  • Screened for small molecules that could induce inverse gene expression changes compared to PTC.

Main Results:

  • Identified 2,154 differentially expressed genes (DEGs) in PTC compared to normal tissues (FDR < 0.01).
  • DEGs were significantly enriched in 17 pathways, including signal transduction, tumorigenesis, and metabolism.
  • Discovered numerous small molecules with the potential to reverse PTC-associated molecular alterations.

Conclusions:

  • The study provides a comprehensive molecular landscape of PTC, highlighting key pathways involved in its development.
  • Identified small molecules represent promising candidates for further investigation as novel therapeutic agents for papillary thyroid cancer.
  • These findings offer new directions for drug discovery and therapeutic development in PTC management.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...